Coldstream Capital Management Inc Immunome Inc. Put Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IMNM
# of Institutions
141Shares Held
56.6MCall Options Held
52.8KPut Options Held
3.56M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.55MShares$67 Million0.03% of portfolio
-
Redmile Group, LLC San Francisco, CA4.83MShares$42.8 Million3.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.31MShares$38.2 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$36.2 Million2.16% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$33.3 Million0.0% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $108M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...